Lavipharm S.A. announced earnings results for the year ended December 31, 2011. For the year, the company reported total revenue of EUR 168.7 million against EUR 168.43 million a year ago. Operating loss was EUR 3.99 million against operating income of EUR 6.14 million a year ago.

Pre-tax loss was EUR 13.44 million against pre-tax income of EUR 0.88 million a year ago. Total net loss was EUR 10.39 million against EUR 3.75 million a year ago. Cash from operating activities was EUR 14.88 million against EUR 1.13 million a year ago.

Capital expenditures was EUR 0.82 million against EUR 0.47 million a year ago. Negative return on equity was 59.44% against 13% a year ago. Negative return on assets was 7.13% against 1.95% a year ago.